Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
130.25
+2.74 (2.15%)
May 28, 2026, 1:02 PM EDT - Market open
Guardant Health Stock Forecast
Stock Price Forecast
According to 22 analysts polled by S&P Global, Guardant Health stock has a consensus rating of "Strong Buy" and an average price target of $131.24. The average 1-year stock price forecast is 0.76% higher than the current stock price, while the lowest is $90 (-30.90%) and the highest is $190 (+45.87%).
Price Target: $131.24 (+0.76%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Guardant Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 17 | 16 | 17 | 16 | 16 | 16 |
| Buy | 5 | 5 | 5 | 5 | 4 | 4 |
| Hold | 0 | 1 | 2 | 2 | 2 | 1 |
| Sell | 1 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 1 | 0 | 0 | 0 | 0 |
| Total | 23 | 23 | 24 | 23 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $97 → $130 | Buy | Maintains | $97 → $130 | -0.19% | May 27, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 27, 2026 |
| BTIG | BTIG | Buy Reiterates $155 → $160 | Buy | Reiterates | $155 → $160 | +22.84% | May 26, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $130 → $135 | Buy | Reiterates | $130 → $135 | +3.65% | May 12, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $135 | Buy | Reiterates | $135 | +3.65% | May 11, 2026 |
Financial Forecast
Revenue This Year
1.35B
from 982.02M
Increased by 37.37%
Revenue Next Year
1.73B
from 1.35B
Increased by 28.24%
EPS This Year
-1.60
from -3.32
EPS Next Year
-0.62
from -1.60
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1.4B | 1.9B | ||||||
| Avg | 1.3B | 1.7B | ||||||
| Low | 1.2B | 1.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 41.0% | 41.3% | ||||||
| Avg | 37.4% | 28.2% | ||||||
| Low | 26.8% | 15.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -1.31 | -0.14 | ||||||
| Avg | -1.60 | -0.62 | ||||||
| Low | -2.89 | -1.03 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.